Kinetics and management of adverse events associated with lorlatinib after 5 years of follow-up in the CROWN study
- DOI
- 10.1093/oncolo/oyaf287
- Published
- 2025-10-01
- Container
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyaf287,
title = {Kinetics and management of adverse events associated with lorlatinib after 5 years of follow-up in the CROWN study},
author = {Geoffrey Liu and Benjamin J Solomon and Julien Mazieres and Dong-Wan Kim and Diego Cortinovis and Takako Inoue and Richu Sharma and Holger Thurm and Anna Polli and Todd M Bauer},
year = {2025},
journal = {The Oncologist},
doi = {10.1093/oncolo/oyaf287},
url = {https://doi.org/10.1093/oncolo/oyaf287}
}RIS
TY - JOUR TI - Kinetics and management of adverse events associated with lorlatinib after 5 years of follow-up in the CROWN study AU - Geoffrey Liu AU - Benjamin J Solomon AU - Julien Mazieres AU - Dong-Wan Kim AU - Diego Cortinovis AU - Takako Inoue AU - Richu Sharma AU - Holger Thurm AU - Anna Polli AU - Todd M Bauer PY - 2025 JO - The Oncologist DO - 10.1093/oncolo/oyaf287 UR - https://doi.org/10.1093/oncolo/oyaf287 ER -
APA
Liu, G., Solomon, B. J., Mazieres, J., Kim, D., Cortinovis, D., Inoue, T., Sharma, R., Thurm, H., Polli, A., & Bauer, T. M. (2025). Kinetics and management of adverse events associated with lorlatinib after 5 years of follow-up in the CROWN study. The Oncologist. https://doi.org/10.1093/oncolo/oyaf287
Source records
- crossref · retrieved 2026-09-26T10:49:53.364Z